The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2026

Filed:

Dec. 23, 2022
Applicants:

Fresenius Medical Care Holdings, Inc., Waltham, MA (US);

Fresenius Medical Care Deutschland, Gmbh, Bad Homburg, DE;

Inventors:

Vaibhav Maheshwari, Natick, MA (US);

Paul Chamney, Tring-Herts, GB;

Bernd Eberle, Herschweiler-Pettersheim, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/16 (2006.01); G16H 10/60 (2018.01); G16H 20/40 (2018.01);
U.S. Cl.
CPC ...
A61M 1/1613 (2014.02); G16H 10/60 (2018.01); G16H 20/40 (2018.01); A61M 2205/3327 (2013.01); A61M 2205/52 (2013.01);
Abstract

The described technology generally includes systems and processes for a PD optimization process may operate to estimate, predict, or otherwise determine the value of PD dose variables values based on patient characteristics and/or PD prescription information. In one embodiment, a PD optimization process may be or may include a UFV determination process, operative to determine a predicted UFV for a patient. In some embodiments, the UFV determination process may include training a computational model to generate a predicted UFV output based on input of patient characteristics, PD prescription information, PD outcomes (for instance, UFV), and/or historical information associated with patient characteristics, PD prescription information, and/or PD outcomes. In some embodiments, a feedback control process with continuous Intraperitoneal Pressure (IPP) and hydration status measurements may be used to keep the hydration status of the patient within a target level ran. Other embodiments are described.


Find Patent Forward Citations

Loading…